Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
Nov. 30, 2013
Nov. 30, 2012
Current Assets    
Cash and cash equivalents $ 22,971   
Accounts receivable, less allowance of $0 7,757  
Prepaid expenses 12,000  
Total current assets 42,728  
TOTAL ASSETS 42,728  
Current Liabilities    
Accounts Payable and accrued liabilities 6,324  
Total current liabilities 6,324  
TOTAL LIABILITIES 6,324  
COMMITMENTS AND CONTINGENCIES (NOTE 7)      
STOCKHOLDERS' EQUITY    
Preferred stock, 15,000,000 shares authorized; par value $0.0001, none issued and outstanding      
Common stock, 100,000,000 shares authorized; par value $0.0001, 5,825,000 and 950,000 shares issued and outstanding, respectively 583 95
Additional paid-in capital 55,117 855
Deficit accumulated during the development stage (19,194) (950)
Accumulated other comprehensive loss (102)  
Total Stockholders' Equity 36,404   
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 42,728